Aureobasidium.org

In Vitro 2007

LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma

Kim S., Kim Y., Kim J., Park M. · Anticancer Res · PMID: 17465200
Research Archive
TL;DR — Key Findings
  • LKB1 and DAP3 cooperated in apoptosis signaling in osteosarcoma cells.
  • A kinase-dead LKB1 mutant reduced DAP3-related apoptosis in the experiment.
  • The paper is unrelated to beta-glucan and provides no clinical treatment evidence.

Abstract

This cell study examined signaling involved in TRAIL-induced apoptosis in osteosarcoma. The researchers found that the kinase LKB1 associated with DAP3, a protein involved in activation of procaspase-8. Expression of either protein promoted apoptosis in osteosarcoma cells, while co-expression produced a stronger response; a kinase-dead LKB1 mutant reduced DAP3-related apoptosis. These experiments identify a possible role for LKB1 and DAP3 in tumor-cell death signaling. They do not test beta-glucan, a treatment in animals or patients, or the clinical value of LKB1 as a biomarker.

Summary

Summary

Study design

Osteosarcoma cell experiments tested interactions among LKB1, DAP3, and TRAIL-related apoptosis.

Interpretation

The findings are mechanistic and do not establish a treatment effect or biomarker utility in patients.

Citation

Kim S., Kim Y., Kim J., Park M.. LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma. Anticancer Res. 2007. PMID: 17465200.

Study Details
Study Type
In Vitro
Published
2007
Journal
Anticancer Res
Authors
Kim S., Kim Y., Kim J., Park M.
PubMed ID
17465200
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.